Does biliopancreatic diversion carry increased risk for colorectal cancer? A cohort study

Obesity Surgery

Volumn 18, Issue 2, 2008, Pages 212-215

  Adami, Gian Franco ^a   Papadia, Francesco S ^a   Marinari, Giuseppe M ^a   Camerini, Giovanni B ^a   Scopinaro, Nicola ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Bariatric surgery; Biliopancreatic diversion; Colorectal cancer; Morbid obesity

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BILIOPANCREATIC BYPASS; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; ITALY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD;

ADULT; AGED; BILIOPANCREATIC DIVERSION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 39149137174     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-007-9348-z     Document Type: Article

References (28)

1. Potter JD. Nutrition and colorectal cancer. Cancer Causes Control 1996;7:127-46.
2. Lipkin M, Reddy B, Newmark H, Lamprecht SA. Dietary factors in human colorectal cancer. Ann Rev Nutr 1999;19:545-86.
3. Martinez ME, Giovannucci E. Diet and the prevention of cancer. Cancer Metastasis Rev 1997;16:357-76.
4. Harris DM, Go VL. Vitamin D and colon carcinogenesis. J Nutr 2004;134:3463S-71S.
5. Martinez ME, Willett WC. Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomark Prev 1998;7:163-8.
6. Harris PJ, Ferguson LR. Dietary fibres may protect or enhance carcinogenesis. Mutat Res 1999;443:95-110.
7. Chaplin MF. Bile acids, fibre and colon cancer: the story unfolds. J R Soc Health 1998;118:53-61.
8. Debruyne PR, Bruyneel EA, Li X, Zimber A, Gespach C, Mareel MM. The role of bile acids in carcinogenesis. Mutat Res 2001;480-481:359-69.
9. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg 1998;22:936-46.
10. Scopinaro N, Gianetta E, Civalleri D, et al. Biliopancreatic bypass. In: Griffen WO, Printen KJ, editors. Surgical management of obesity. Marcel Decker: New York and Basel; 1987. p. 93-161.
11. Moore LL, Bradlee ML, Singer MR, et al. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study. Int J Obes Relat Metab Disord 2004;28:559-67.
12. MacInnis RJ, English DR, Hopper JL, et al. Body size and composition and colon cancer risk in men. Cancer Epidemiol Biomark Prev 2004;13:553-9.
13. Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007;132:2208-25.
14. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007;86:556-65.
15. Adami GF, Cordera R, Camerini G, Marinari GM, Scopinaro N. Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity. Int J Obes Relat Metab Disord 2004;28:671-3.
16. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006;55:2025-31.
17. Capocaccia R, De Angelis R, Frova L, et al. Estimation and projections of colorectal cancer trends in Italy. Int J Epidemiol 1997;26:924-32.
18. Hu FB, Manson JE, Liu S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999;91:542-7.
19. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002;38:99-166.
20. Verdecchia A, Micheli A, Colonna M, Moreno V, Izarzugaza MI, Paci E; EUROPREVAL Working Group. A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain. Ann Oncol 2002;13:1128-39.
21. Ponz de Leon M, Marino M, Benatti P, et al. Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. Ann Oncol 2004;15:940-6.
22. Adami GF, Papadia FS, Scopinaro N. Colorectal cancer after biliopancreatic diversion for obesity. Int J Obes (Lond) 2007 Dec;31(12):1864. Epub 2007 Jun 19.
23. Yang YX, Hennessy S, Lewis JD. Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol 2005;3:587-94.
24. Will JC, Galuska DA, Vinicor F, Calle EE. Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 1998;147:816-25.
25. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995;6:164-79.
26. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131:3109S-20S.
27. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomark Prev 1994;3:687-95.
28. Scopinaro N, Marinari GM, Camerini GB, Papadia FS, Adami GF. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care 2005;28(10):2406-11.